Research Article
Topological Indices of Novel Drugs Used in Diabetes Treatment and Their QSPR Modeling
Table 17
Comparison of actual and computed values for refractive index from regression models.
| Name of drug | Refractivity of drug | Refractivity computed from regression model for ABC(G) index | Refractivity computed from regression model for R(G) index | Refractivity computed from regression model for S(G) index | Refractivity computed from regression model for GA(G) index | Refractivity computed from regression model for M1(G) index | Refractivity computed from regression model for M2(G) index | Refractivity computed from regression model for F(G) index | Refractivity computed from regression model for H(G) index | Refractivity computed from regression model for HM(G) index |
| Acarbose | 139.02 | 155.534 | 160.469 | 159.089 | 158.081 | 156.566 | 158.069 | 157.417 | 156.732 | 161.762 | Tolazamide | 81.34 | 87.0728 | 86.0361 | 85.8203 | 86.0013 | 87.662 | 88.505 | 89.041 | 88.344 | 85.2994 | Miglitol | 48.16 | 66.8545 | 69.0227 | 68.0669 | 68.0110 | 69.914 | 73.545 | 73.501 | 73.174 | 69.3471 | Prandin | 131.83 | 130.774 | 130.808 | 130.167 | 129.418 | 127.856 | 125.718 | 125.597 | 124.916 | 130.191 | Metformin | 56.64 | 49.4407 | 50.6662 | 49.9496 | 49.394 | 49.556 | 49.983 | 50.857 | 50.296 | 50.8057 | Glimepiride | 129.8 | 130.063 | 127.935 | 127.402 | 126.928 | 128.378 | 126.84 | 128.705 | 127.048 | 126.099 | Linagliptin | 133.43 | 123.700 | 122.189 | 123.582 | 123.794 | 121.592 | 118.799 | 117.901 | 117.618 | 122.925 | Pioglitazone | 97.39 | 92.2844 | 92.7146 | 93.4237 | 93.4718 | 91.316 | 90.749 | 89.189 | 89.41 | 93.5679 | Bromocriptine | 165.51 | 157.9 | 153.567 | 155.451 | 157.267 | 159.698 | 161.248 | 159.785 | 159.438 | 152.700 | Alogliptin | 104.26 | 93.6658 | 94.0577 | 94.3332 | 94.8948 | 93.926 | 94.863 | 92.889 | 93.264 | 94.6119 |
|
|